Buy Delcath Systems Stock | DCTH Stock Price & Latest News | Public
DCTH

Delcath Systems

$0.00 (0.00%)Today
    Small Market Cap

    About DCTH

    Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -36.02
    -72.05
    -108.07
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$1.12

    Actual EPS
    Q4 2020

    Stats

    Market Cap$68,99M
    Volume3,59k
    Price-to-Earnings Ratio0.22
    Dividend Rate
    Dividend Yield
    1 Year High$19.82
    1 Year Low$0.04
    Open$16.90
    High$17.00
    Low$15.79

    Buy any stock with any amount of money.

    Download the App
    Download the app